Synthetic low-calcaemic vitamin D3 analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells

Molecular and Cellular Endocrinology

Volumn 183, Issue 1-2, 2001, Pages 141-149

  Oh, Yoon S ^a   Kim, Eun J ^a   Schaffer, Beverly S ^b   Kang, Young H ^a   Binderup, Lise ^c   MacDonald, Richard G ^b   Park, Jung H Y ^a  

^a Hallym University   (South Korea)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c LEO PHARMA A S   (Denmark)

Author keywords

1 ,25 Dihydroxyvitamin D3; CB1093; Colon cancer cells; EB1089; Insulin like growth factor; Insulin like growth factor binding proteins; Vitamin D

Indexed keywords

1BETA,25 DIHYDROXYCOLECALCIFEROL; 20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; CALCITRIOL; COLECALCIFEROL DERIVATIVE; SEOCALCITOL; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 6;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HT29; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION;

ANIMALS; CELL DIVISION; CHOLECALCIFEROL; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; HT29 CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; INSULIN-LIKE GROWTH FACTOR II;

EID: 0035950393     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00598-6     Document Type: Article

References (49)

1. Vitamin D3 analogue (EB1089) inhibits in vitro cellular proliferation of human colon cancer cells
2. Insulin-like growth factor binding protein-6: the 'forgotten' binding protein?
3. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins1-6
4. Human insulin-like growth factor binding protein-6 is O-glycosylated
5. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities
6. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential
7. Relation of calcium, vitamin D, and daily food intake to incidence of colon cancer among older women
8. A reagent for the single-step simultaneous isolation of RNA, DNA and protein from cell and tissue samples
9. EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro
10. Production of insulin-like growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon carcinoma cell line
11. Rapid colorimetric assay for cell growth and survival: modifications of the tetrazolium dye procedure giving improved sensitivity and reliability
12. Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29
13. Vitamin D: metabolism and action
14. Editorial/mini-review: vitamin D and prostate cancer
15. Can colon cancer incidence and death rates be reduced with calcium and vitamin D?
16. Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells
17. EB1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells
18. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed
19. Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines
20. Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089
21. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells
22. Insulin-like growth factors and their binding proteins: biological actions
23. Inhibition of Caco-2 cell proliferation by (n-3) fatty acids: possible mediation by increased secretion of insulin-like growth factor binding protein-6
24. Blockade of the insulin-like growth factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop
25. Insulin-like growth factor II in two human colon-carcinoma cell lines: gene structure and expression, and protein secretion
26. Vitamin D: anticancer and differentiation
27. Purification and amino-terminal sequence of an insulin-like growth factor-binding protein secreted by rat liver BRL-3A cells
28. IGF-independent regulation of breast cancer growth by IGF binding proteins
29. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation
30. Interactions of vitamin D analogue CB1093, TNFalpha and ceramide on breast cancer cell apoptosis
31. des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cell
32. Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. Unique apical sorting of insulin-like growth factor binding protein-4 in differentiated human colon cancer cells
33. Circulating insulin-like growth factor II and colorectal adenomas
34. Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins
35. Inhibition of insulin-like growth factor 1 receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: a role for insulin-like growth factor binding proteins
36. Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation
37. 1,25-Dihydroxyvitmain D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition
38. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3
39. Isolation and molecular cloning of insulin-like growth factor-binding protein-6
40. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I
41. Expression of IGF-II and IGF-binding proteins by colon cancer cells in relation to growth response to IGFs
42. Insulin-like growth factors and binding proteins in colon cancer
43. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors
44. Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial cell line 18,54-SF: application of a monoclonal antibody
45. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089
46. Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells
47. Role of the insulin-like growth factor family in cancer development and progression
48. Gene expression profiles in normal and cancer cells